Menu Philippe 4

What Happened

• Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA (SOPH), sold 608 shares in an open-market transaction on May 19, 2026. The weighted-average sale price was $4.61 per share for a reported total of approximately $2,800. This was a sale (code S) executed to satisfy tax withholding tied to RSUs that vested on May 18, 2026, and therefore is a routine, non-discretionary transaction under a pre-established Rule 10b5-1(c) plan.

Key Details

• Transaction date: 2026-05-19; weighted average price: $4.61; reported total proceeds: $2,800.
• Price range: shares were sold in multiple trades at prices from $4.54 to $4.66 (inclusive). The filer can provide a breakdown of the number sold at each price upon written request (see footnote F2).
• Reason: Sales were made to satisfy tax withholding on RSU vesting on 2026-05-18 and were effected under a pre-established Rule 10b5-1(c) plan (footnote F1).
• Shares owned after transaction: not disclosed in the provided filing details.
• Filing: Form 4 filed 2026-05-20 for a 2026-05-19 transaction — filed the next day (timely).

Context

• These sales were tax-withholding related and governed by a 10b5-1 plan, meaning they were pre-set and not discretionary trades by the insider. Such routine sell-to-cover transactions generally do not signal a change in insider confidence.